This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

V. E. H. BROOKS, MD; ROLF RICHARDS, MB, MRCP

Arch Intern Med. 1966;117(5):677-680.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE endocrinological control of pigmentation has been a subject of considerable interest and much investigation. Lerner et al ¹ and Lerner,² in comprehensive reviews, discussed the etiological factors associated with melanin pigmentation. They observed that primary adrenal insufficiency is usually associated with hyperpigmentation, but that adrenal insufficiency secondary to hypopituitism is not. They further suggested that this hyperpigmentation is dependent upon an increase in the circulating levels of the melanocyte stimulating hormone (MSH) and could be controlled by maintenance doses of hydrocortisone. In addition, increased levels of MSH have been detected in the urine of patients suffering from Addison's disease.³

Hyperpigmentation has also been reported following adrenalectomy for Cushing's syndrome where an excessive production of adrenocorticotrophic hormone (ACTH) has persisted following operation.⁴ In some of these cases an ACTH-producing pituitary tumor has become manifest and the implication has been that the increase of pigment in these patients . . . [Full Text PDF of this Article]

Author Affiliations
KINGSTON, JAMAICA

From the departments of medicine and surgery, University of the West Indies, Kingston.

Footnotes
Received for publication Sept 6, 1965; accepted Nov 15.

Reprint requests to Department of Surgery, University of the West Indies, Kingston, Jamaica (Dr. Brooks).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?